E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/23/2022 in the Prospect News Structured Products Daily.

New Issue: Citigroup prices $1 million callable contingent coupon securities on biotech ETF

Chicago, Aug. 23 – Citigroup Global Markets Holdings Inc. priced $1 million of callable contingent coupon equity linked securities due Jan. 24, 2023 linked to the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.

Investors will receive a coupon of 12% paid monthly if the ETF closes at or above its 62.5% coupon barrier on the related valuation date.

The securities may be called at par starting Feb. 22 and on any subsequent monthly review date.

The payout at maturity will be par if the ETF ends at or above its 62.5% final barrier. Otherwise, investors will lose 1% for every 1% that the ETF declines.

The notes are guaranteed by Citigroup Inc.

Citigroup Global Markets Inc. is the agent.

Issuer:Citigroup Global Markets Holdings Inc.
Guarantor:Citigroup Inc.
Issue:Callable contingent coupon equity linked securities
Underlying ETF:SPDR S&P Biotech ETF
Amount:$1 million
Maturity:Jan. 24, 2023
Coupon:12% annual rate, paid monthly if the ETF closes at or above its 62.5% coupon barrier on the related valuation date
Price:Par
Payout at maturity:If ETF finishes at or above final barrier par; 1% loss for every 1% that ETF declines if it ends below final barrier
Call:At par starting Feb. 22 and on any subsequent monthly review date at issuer’s option
Initial level:$94.52
Coupon barrier:$59.075, 62.5% of initial level
Final barrier:$59.075, 62.5% of initial level
Pricing date:Jan. 19
Settlement date:Jan. 24
Agent:Citigroup Global Markets Inc.
Fees:0.2%
Cusip:17330A5C2

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.